From 1999 to 2019, there was a decrease in the sepsis-related mortality rate in children overall and across demographic groups.

Clinical response to microbiota-based treatment with RBL for recurrent CDI prevention was associated with significant restoration of microbiota and bile acid composition ...

COVID-19 2024–2025 vaccines are recommended for everyone aged 6 months and older, with vaccines targeting the JN.1 and KP.2 strains of SARS-CoV-2.

Implementation of an electronic health record order set increases compliance with the recommended duration of prescribed antibiotics for children with acute otitis media.

COVID-19 vaccination is associated with a reduced risk for most CV events, but with slightly increased risks for extrasystoles and transient ischemic attack, as well as myocarditis and pericarditis ...

Lyme disease epidemiologic trends for sex, age, and region are similar for Medicare diagnoses and cases identified through public health surveillance.

The MVA-BN vaccine, licensed in the United States to prevent smallpox and mpox, is well tolerated and seems effective in adolescents.

Early antiviral therapy with obeldesivir was safe and well tolerated in patients at high risk for severe COVID-19 and ...

A single COVID-19 mRNA vaccine dose provided similar protection to that conferred by a 2-dose series among immunocompetent ...

Older adults who received the bivalent BNT162b2 vaccine were less likely to develop long COVID symptoms follow acute ...

In patients with uncomplicated UTI, the presence of positive vs negative ESBL uropathogens differed by symptom severity, race, and age plus recurrent UTI history.

The policy of billing for secure messages changes patient expectations and can impact the patient-physician relationship.